• Team

    Europe

    • A. Muraro, Referral Centre for Food Allergy Veneto Region Department of Pediatrics – University of Padua, Italy
    • M. Fernandez-Rivas, Hospital Clinico San Carlos Madrid, Spain
    • D. Sabouraud, Allergyvigilance Network, Vandoeuvre les Nancy, France
    • M. Worm, Department for Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Germany

    UK

    • PJ. Turner, Imperial College London, UK
    • A. Baseggio Conrado, Imperial College London, UK
    • MH. Gowland, Allergy Action - St Albans, UK
    • The British Society for Allergy & Clinical Immunology (BSACI), UK
    • Paediatric Emergency Research in the UK and Ireland (PERUKI), UK
    • M. Worm, Department for Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Germany

    Brazil

    • LF. Ensina, Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo (UNIFESP), Brazil
    • M. Worm, Department for Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Germany

     

     

  • Statistics

    Status: Friday, 18. November 2022

    12504 completed cases

    Male patients 5855 47%
    Female patients 6649 53%
    Children and youths 2964 24%
    Adults 9540 76%

    completed cases per country:

    Germany 9236 74%
    Austria 1013 8%
    Switzerland 2255 18%

    1680 completed cases

    Male patients 917 55%
    Female patients 763 45%
    Children and youths 793 47%
    Adults 887 53%

    2801 completed cases

    Male patients 1564 56%
    Female patients 1237 44%
    Children and youths 1162 41%
    Adults 1639 59%

    completed cases per country:

    Brazil 221 8%
    Bulgaria 254 9%
    Greece 362 13%
    Ireland 205 7%
    Italy 771 28%
    Poland 380 14%
    Spain 527 19%
    Romania 81 3%